Analysts’ Weekly Ratings Changes for Aspira Women’s Health (AWH)

A number of firms have modified their ratings and price targets on shares of Aspira Women’s Health (NASDAQ: AWH) recently:

• 12/31/2024 – Aspira Women’s Health is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.
• 12/25/2024 – Aspira Women’s Health is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.
• 12/19/2024 – Aspira Women’s Health is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.
• 12/13/2024 – Aspira Women’s Health is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.
• 12/7/2024 – Aspira Women’s Health is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.
• 12/1/2024 – Aspira Women’s Health is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.
• 11/25/2024 – Aspira Women’s Health is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.
• 11/19/2024 – Aspira Women’s Health is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.
• 11/13/2024 – Aspira Women’s Health is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.
• 11/7/2024 – Aspira Women’s Health is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.

Aspira Women’s Health Trading Up 0.3 %

NASDAQ AWH traded up $0.00 during trading hours on Wednesday, reaching $0.71. The company’s stock had a trading volume of 87,496 shares, compared to its average volume of 77,288. The business has a 50-day simple moving average of $0.80 and a 200 day simple moving average of $1.00. Aspira Women’s Health Inc. has a 52 week low of $0.67 and a 52 week high of $5.65. The stock has a market cap of $11.75 million, a PE ratio of -0.59 and a beta of 1.39.

Institutional Trading of Aspira Women’s Health

A hedge fund recently bought a new stake in Aspira Women’s Health stock. Pine Valley Investments Ltd Liability Co purchased a new stake in shares of Aspira Women’s Health Inc. (NASDAQ:AWH) in the third quarter, according to its most recent disclosure with the SEC. The firm purchased 31,200 shares of the company’s stock, valued at approximately $25,000. Pine Valley Investments Ltd Liability Co owned approximately 0.19% of Aspira Women’s Health as of its most recent filing with the SEC. Hedge funds and other institutional investors own 12.19% of the company’s stock.

Aspira Women's Health Inc, together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass.